Literature DB >> 1550179

Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid.

G R Howard1, J A Nerad, K D Carter, D C Whitaker.   

Abstract

Over a six-year period, between 1984 and 1990, 622 patients with basal cell and squamous cell carcinoma of the eyelids were examined at our institution. Thirteen patients had orbital invasion at initial examination. The average age of patients at orbital invasion was 75.8 years. Ten patients were men, eight of whom had basal cell carcinoma and two of whom had squamous cell carcinoma. Most patients had an orbital mass and incomitant strabismus at initial examination. Invasive basal cell carcinoma developed in 11 patients, and squamous cell carcinoma developed in two patients. Ten patients were treated for cutaneous carcinoma at the site of invasion before examination at our institution. The average duration between onset of a cutaneous lesion and our examination for orbital invasion was 9.8 years for basal cell carcinoma and one year for squamous cell carcinoma. Radiologic and histopathologic features were reviewed. The clinical characteristics of these patients were reviewed and orbital exenteration was recommended to all 13 patients. Nine patients underwent exenteration and four refused the operation.

Entities:  

Mesh:

Year:  1992        PMID: 1550179     DOI: 10.1016/s0002-9394(14)71523-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

1.  5 years review of periocular basal cell carcinoma and proposed follow-up protocol.

Authors:  S F Ho; L Brown; M Bamford; R Sampath; J Burns
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

2.  Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival.

Authors:  R C Gerring; C T Ott; J M Curry; Z B Sargi; S T Wester
Journal:  Eye (Lond)       Date:  2016-10-21       Impact factor: 3.775

3.  Invasive squamous cell carcinoma of the eyelids and periorbital region.

Authors:  Hülya Gökmen Soysal; Fatma Markoç
Journal:  Br J Ophthalmol       Date:  2006-10-04       Impact factor: 4.638

4.  Squamous cell carcinoma of the eyelids.

Authors:  M J Donaldson; T J Sullivan; K J Whitehead; R M Williamson
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

5.  Small margin excision of periocular basal cell carcinoma: 5 year results.

Authors:  J D Hsuan; R A Harrad; M J Potts; C Collins
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

6.  Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.

Authors:  Alena Furdova; Pavol Lukacko
Journal:  J Craniofac Surg       Date:  2017-01       Impact factor: 1.046

7.  Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases.

Authors:  Kai Yuen Wong; Kate Fife; John T Lear; Richard D Price; Amer J Durrani
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-21

8.  Reconstruction of Medial Canthal Tendon Using Novel Suture Anchoring System: A Case Report.

Authors:  Natsuko Kakudo; Masayasu Takegawa; Masakatsu Hihara; Naoki Morimoto; Hiromu Masuoka; Kenji Kusumoto
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-10-15

9.  Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial.

Authors:  Alon Kahana; Shelby P Unsworth; Christopher A Andrews; May P Chan; Scott C Bresler; Christopher K Bichakjian; Alison B Durham; Hakan Demirci; Victor M Elner; Christine C Nelson; Denise S Kim; Shannon S Joseph; Paul L Swiecicki; Francis P Worden
Journal:  Oncologist       Date:  2021-05-31

Review 10.  Management of high-risk and advanced basal cell carcinoma.

Authors:  S Puig; A Berrocal
Journal:  Clin Transl Oncol       Date:  2015-02-03       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.